Well parent company snags ‘iconic’ late Queen’s pharmacy John Bell & Croyden

Well Pharmacy parent company Bestway Healthcare has acquired luxury pharmacy John Bell & Croyden from Lloydspharmacy’s holding company.

Bestway told C+D that it is “delighted to welcome" the pharmacy and its 85-strong team to the "family”

Well CEO Seb Hobbs announced via LinkedIn that the company has acquired the London business from Lloydspharmacy holding company Hallo Healthcare.

John Bell & Croyden held a Royal Warrant, serving as the official pharmacy of the late Queen Elizabeth.

Read more: Inside the Queen’s pharmacy: From flu jabs to the coronation anointing oil

Bestway acquired the Marylebone business for an undisclosed sum following a short process, Well told C+D.

John Bell & Croyden will not be integrated into Well but will operate as a standalone within Bestway’s retail pharmacy operation, a spokesperson confirmed.

“Delighted”

Andrew Caplan, chief retail officer at Bestway, told C+D this week (August 9) that the company is “delighted to welcome John Bell & Croyden to the Bestway family”, along with its 85-strong team.

“We respect its 225-year heritage, luxury proposition and unique position in the London market,” he said.

He added that the company is “excited to own such an admired brand and to be working with a terrific team who we will support to grow the business and its reputation further”.

Read more: UPDATED: Well Pharmacy snaps up 11 Lloydspharmacy branches in Scotland

The “iconic” business has a “rich heritage in pharmacy” and has been a “landmark” in central London for more than two centuries, Mr Caplan said.

“This acquisition aligns closely with our strategic growth aspirations and reflects our continued confidence in the future of pharmacy,” he added.

A Well spokesperson told C+D that the pharmacy will continue to be led by operations director Robin Winfield who will report into Mr Caplan.

Historic pharmacy

“Pioneering” pharmacist John Bell opened the original pharmacy on Oxford Street in 1798, according to its website.

His son Jacob Bell founded the Pharmaceutical Society in 1841 – now known as the Royal Pharmaceutical Society (RPS) – it said.

Read more: From the archive - The Queen’s Pharmacy

In 1928, the business was acquired by pharmacy company Savory & Moore and was passed between various owners before becoming part of Hallo Healthcare.

John Bell & Croyden held the Royal Warrant as pharmacists to the late Queen Elizabeth II from 1958 until her death in 2022, according to its website.

It remains unclear which pharmacy now holds the Royal Warrant.

Sign in or register for free

Kate Bowie

Read more by Kate Bowie

Kate Bowie joined C+D as a digital reporter in August 2023 after graduating from a master’s in journalism at City, University of London. She began covering the primary care beat at the end of 2022, when she carried out several health investigations focused on staffing issues, NHS funding and health inequalities.

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.